Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Expert Opinion on Therapeutic Targets
|
November 22, 2021
Uncovering key targets of success for immunotherapy in pancreatic cancer
Andrea Pretta, Eleonora Lai, Mara Persano, et al.
Clinical Genitourinary Cancer
|
October 15, 2024
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study
Annalisa Guida, Alessio Gili, Claudia Mosillo, et al.
Cancers
|
April 27, 2024
CD44: A New Prognostic Marker in Colorectal Cancer?
Pina Ziranu, Andrea Pretta, Valentina Aimola, et al.
Cancer Treatment Reviews
|
November 19, 2019
New therapeutic targets in pancreatic cancer
Eleonora Lai, Marco Puzzoni, Pina Ziranu, et al.
Journal of Kidney Cancer and VHL
|
October 20, 2025
Meet-URO Score Validation in Real-world Patients with Metastatic Renal Cell Carcinoma Receiving First-line Pembrolizumab Plus axitinib: A Subanalysis of the Prospective ProPAXI Study
Giulia Airò, Annalisa Guida, Alessio Gili, et al.
Clinical Colorectal Cancer
|
August 25, 2021
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study
Eleonora Lai, Marco Puzzoni, Pina Ziranu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 7, 2024
Early taxane exposure and neurotoxicity in breast cancer patients
Erika Cimbro, Mariele Dessì, Pina Ziranu, et al.
Frontiers in Oncology
|
May 9, 2022
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients
Stefano Mariani, Marco Puzzoni, Riccardo Giampieri, et al.
Targeted Oncology
|
February 6, 2020
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study
Luca Faloppi, Marco Puzzoni, Andrea Casadei Gardini, et al.
Targeted Oncology
|
November 10, 2020
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study
Luca Faloppi, Marco Puzzoni, Andrea Casadei Gardini, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Expert Opinion on Therapeutic Targets
|
November 22, 2021
Uncovering key targets of success for immunotherapy in pancreatic cancer
Andrea Pretta, Eleonora Lai, Mara Persano, et al.
Clinical Genitourinary Cancer
|
October 15, 2024
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study
Annalisa Guida, Alessio Gili, Claudia Mosillo, et al.
Cancers
|
April 27, 2024
CD44: A New Prognostic Marker in Colorectal Cancer?
Pina Ziranu, Andrea Pretta, Valentina Aimola, et al.
Cancer Treatment Reviews
|
November 19, 2019
New therapeutic targets in pancreatic cancer
Eleonora Lai, Marco Puzzoni, Pina Ziranu, et al.
Journal of Kidney Cancer and VHL
|
October 20, 2025
Meet-URO Score Validation in Real-world Patients with Metastatic Renal Cell Carcinoma Receiving First-line Pembrolizumab Plus axitinib: A Subanalysis of the Prospective ProPAXI Study
Giulia Airò, Annalisa Guida, Alessio Gili, et al.
Clinical Colorectal Cancer
|
August 25, 2021
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study
Eleonora Lai, Marco Puzzoni, Pina Ziranu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 7, 2024
Early taxane exposure and neurotoxicity in breast cancer patients
Erika Cimbro, Mariele Dessì, Pina Ziranu, et al.
Frontiers in Oncology
|
May 9, 2022
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients
Stefano Mariani, Marco Puzzoni, Riccardo Giampieri, et al.
Targeted Oncology
|
February 6, 2020
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study
Luca Faloppi, Marco Puzzoni, Andrea Casadei Gardini, et al.
Targeted Oncology
|
November 10, 2020
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study
Luca Faloppi, Marco Puzzoni, Andrea Casadei Gardini, et al.
Page
of 8